{"id":240,"date":"2019-03-05T16:49:47","date_gmt":"2019-03-05T07:49:47","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=240"},"modified":"2022-10-03T17:56:09","modified_gmt":"2022-10-03T08:56:09","slug":"2018-2","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/works\/2018-2\/","title":{"rendered":"2018"},"content":{"rendered":"

\u539f\u8457\u8ad6\u6587<\/strong><\/p>\n

    \n
  1. Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Nishii R, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y. In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate. Nucl Med Biol. 2018;56:21-25.<\/li>\n
  2. Nishihira K, Shibata Y, Yamashita A, Kuriyama N, Asada Y. Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction. Atherosclerosis. 2018;268:138-144.<\/li>\n
  3. Sawaguchi A, Kamimura T, Yamashita A, Takahashi N, Ichikawa K, Aoyama F, Asada Y. Informative three-dimensional survey of cell\/tissue architectures in thick paraffin sections by simple low-vacuum scanning electron microscopy. Sci Rep. 2018;8:7479.<\/li>\n
  4. Watanabe Y, Koyama S, Yamashita A, Matsuura Y, Nishihira K, Kitamura K, Asada Y. Indoleamine 2,3-dioxygenase 1 in coronary atherosclerotic plaque enhances tissue factor expression in activated macrophages. Res Pract Thromb Haemost. 2018;2:726-735.<\/li>\n
  5. Itami H, Hara S, Matsumoto M, Imamura S, Kanai R, Nishiyama K, Ishimura M, Ohga S, Yoshida M, Tanaka R, Ogawa Y, Asada Y, Sekita-Hatakeyama Y, Hatakeyama K, Ohbayashi C. Complement activation associated with ADAMTS13 deficiency may contribute to the characteristic glomerular manifestations in Upshaw-Schulman syndrome. Thromb Res. 2018 Sep 1;170:148-155.<\/li>\n
  6. Yamasaki K, Mukai S, Nagai T, Nakahara K, Fujii M, Terada N, Ohno A, Sato Y, Toda Y, Kataoka H, Kamoto T. Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis. Int J Mol Sci. 2018; 19: E3708.<\/li>\n<\/ol>\n

    \u75c7\u4f8b\u5831\u544a<\/strong><\/p>\n

      \n
    1. Tokumitsu T, Sato Y, Fukushima T, Takeshima H, Sato S, Asada Y. Squash cytology findings of subependymomas: A report of three cases and differential diagnosis. Diagn Cytopathol. 2018; 46:258-262.<\/li>\n
    2. Nishikawa S, Noguchi H, Tokumitsu T, Ohno A, Moriguchi-Goto S, Maekawa K, Asada Y, Moritake H, Kinoshita M, Yamada A, Takamura K, Sato Y. Diagnosis of pediatric neuroblastoma by urine cytology: A case report. Diagn Cytopathol. 2018 ;46: 280-283.<\/li>\n
    3. Yoshioka G, Watanabe N, Koita H, Asada Y, Ashikaga K, Kuriyama N, Shibata Y. Echocardiographic and pathologic findings of wild-type transthyretin senile systemic amyloidosis developed in early 50s. J Echocardiogr. 2018; 16: 187-188.<\/li>\n
    4. Kawagoe Y, Nakayama T, Matuzawa S, Fukushima K, Onishi J, Sato Y, Nagai K, Sameshima H. Epithelial Ovarian Carcinoma associated with metastases to central nervous system: two case reports. Case Reports in Obstetrics and Gynecology. 2018:4301247.<\/li>\n
    5. Ban T, Kawakami H, Kubota Y, Sato Y. Impact of Franseen needle on rapid onsite evaluation and histological examination following endoscopic ultrasonography-guided tissue acquisition in patients with splenic malignant lymphoma. Arab J Gastroenterol. 2018; 19: 91-95.<\/li>\n
    6. Hamada T, Nanashima A, Hiyoshi M, Ikenoue M, Imamura N, Yano K, Fujii Y, Kubota Y, Ban T, Kawakami H, Sato Y. Curative distal pancreatectomy in patients with acinar cell carcinoma of pancreas diagnosed by endoscopic aspiration via esophago-jejunostomy: A successful case report. Int J Surg Case Rep.2018; 42:274-279.<\/li>\n
    7. \u672b\u677e\u88d5\u8cb4\u3001\u6b66\u77f3 \u525b\u3001\u6a2a\u4e0a\u8056\u8cb4\u3001\u4e0a\u539f\u4e45\u751f\u3001\u9b4f \u5cfb\u6d38\u3001\u5c71\u4e0b \u7be4\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u7af9\u5cf6\u79c0\u96c4.\u3000\u60aa\u6027\u8ee2\u5316\u3057,\u9ac4\u8154\u5185\u64ad\u7a2e\u3092\u6765\u3057\u305f\u3068\u601d\u308f\u308c\u308b\u985e\u4e0a\u76ae\u816b\u306e1\u4f8b. \u8133\u795e\u7d4c\u5916\u79d1 2018;46:509-514.<\/li>\n
    8. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6797\u3000\u900f\u3001\u9b4f\u5cfb\u6d38\u3001\u76db\u53e3\u6e05\u9999\u3001\u963f\u842c\u7d2b\u3001\u67f4\u7530\u4f38\u5f18\u3001\u6cb3\u91ce\u6587\u5f70\u3001\u843d\u5408\u8cb4\u88d5\u3001\u6d45\u7530\u7950\u58eb\u90ce: \u4e73\u7ba1\u8840\u7ba1\u8089\u816b\u304b\u3089\u5375\u5de3\u8ee2\u79fb\u3092\u304d\u305f\u3057\u305f1\u4f8b.\u3000\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c(\u4e00\u30c4\u6a4b\u5370\u5237\u682a\u5f0f\u4f1a\u793e), 2018; 9: 27-30.<\/li>\n
    9. \u5927\u91ce\u62db\u4f38, \u91ce\u53e3\u88d5\u53f2, \u5fb3\u6e80\u8cb4\u5b50, \u795e\u7530\u4fee\u53f8, \u5cf0\u677e\u6620\u5b50, \u68ee\u7530\u52dd\u4ee3, \u9ed2\u6728\u6804\u8f1d, \u897f\u5ddd\u8a69\u7e54, \u6cb3\u4e0a\u6d0b, \u6c38\u4e95\u5d07\u656c, \u6885\u5317\u4f73\u5b50,\u4f50\u85e4\u52c7\u4e00\u90ce. \u81b5EUS-FNA\u3067\u814e\u7d30\u80de\u764c\u306e\u8ee2\u79fb\u304c\u7591\u308f\u308c\u305f1\u4f8b. \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a\u96d1\u8a8c. 2018;49: 91-94.<\/li>\n
    10. \u5f8c\u85e4\u88d5\u78e8, \u5927\u897f\u6df3\u4ec1, \u897f\u6751\u7f8e\u5e06\u5b50, \u798f\u5cf6\u548c\u5b50, \u5ddd\u8d8a\u9756\u4e4b, \u6c38\u4e95\u516c\u6d0b, \u9ad8\u59bb\u7f8e\u7531\u8cb4, \u8c37\u53e3\u6676\u4fca, \u671b\u6708\u4ec1\u5fd7, \u4e2d\u91cc\u96c5\u5149, \u4f50\u85e4\u52c7\u4e00\u90ce, \u9bab\u5cf6 \u6d69. \u6297NMDA\u53d7\u5bb9\u4f53\u6297\u4f53\u8133\u708e\u9451\u5225\u306e\u305f\u3081\u8179\u8154\u93e1\u4e0b\u5375\u5de3\u816b\u760d\u6458\u51fa\u8853\u3092\u65bd\u884c\u3057\u305f1\u4f8b\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c 2018; 42: 51-56.<\/li>\n<\/ol>\n

      \u7dcf\u8aac<\/strong><\/p>\n

        \n
      1. Asada Y, Yamashita A, Sato Y, Hatakeyama K. Thrombus Formation and Propagation in the Onset of Cardiovascular Events. J Atheroscler Thromb. 2018; 25: 653-664.<\/li>\n
      2. \u9ed2\u5ca9\u9756\u6df3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4eca\u6751\u5353\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u6559\u80b2\u8b1b\u5ea7\u300c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u3092\u7528\u3044\u305f\u5148\u7aef\u751f\u547d\u79d1\u5b66\u7814\u7a76\u300d\u5faa\u74b0\u5668\u75be\u60a3\uff1a\u8cea\u7684\u8a3a\u65ad\u3092\u76ee\u6307\u3057\u305fMRI\u57fa\u790e\u7814\u7a76\u3068\u81e8\u5e8a\u5fdc\u7528. \u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u96d1\u8a8c. 2018;74:599-605<\/li>\n
      3. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u75c5\u7406\u5b66\u7684\u306b\u898b\u305f\u51a0\u52d5\u8108\u8840\u6813\u75c7\u3068\u8840\u6813\u75c7\u7814\u7a76\u306e\u8a71\u984c\u3001\u65e5\u672c\u51a0\u75be\u60a3\u5b66\u4f1a\u96d1\u8a8c2018; 24 : 143-149.<\/li>\n
      4. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u7279\u96c6\u3000\u8840\u6813\u30fb\u585e\u6813\u75c7, \u8840\u6813\u30fb\u585e\u6813\u75c7\u306e\u75be\u60a3\u6982\u5ff5\u3068\u5206\u985e\u3001\u65e5\u672c\u81e8\u5e8a2018; 76 : 1505-1511.<\/li>\n
      5. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u7d68\u6bdb\u764c\u306e\u75c5\u7406\u50cf. \u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u96d1\u8a8c. 2018; 36:149-154.<\/li>\n<\/ol>\n

        \u5b66\u4f1a\u767a\u8868<\/strong><\/p>\n

          \n
        1. \u6749\u7530\u5343\u6cf0\u3001\u4e2d\u99ac\u7965\u5b50\u3001\u5409\u7530\u6842\u4e8c\u90ce\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5409\u7530\u88d5\u6a39\u3001\u6e21\u8fba\u3000\u6e21\u3001\u5c71\u672c\u9686\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u9ed2\u5ddd\u660c\u5f66. \u30d5\u30e9\u30dc\u30f3\u306b\u5206\u985e\u3055\u308c\u308b\u30d5\u30e9\u30dc\u30ce\u30a4\u30c9\u306e\u8840\u5c0f\u677f\u304a\u3088\u3073\u8840\u6db2\u51dd\u56fa\u7cfb\u306b\u5bfe\u3059\u308b\u5f71\u97ff. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c138\u5e74\u4f1a\uff08\u91d1\u6ca2\u5e02\u30013\/25-28, 2018\uff09<\/li>\n
        2. \u5e73\u7530\u667a\u4e5f\u3001\u5c71\u672c\u4e8c\u6717\u3001\u5e02\u6210\u76f4\u6a39\u3001\u7c73\u6fa4\u745b\u7f8e\u3001\u91ce\u7530\u8cb4\u7a42\u3001\u9234\u6728\u7fd4\u3001\u5742\u53e3\u821e\u3001\u590f\u7530\u6731\u4e00\u90ce\u3001\u5b89\u500d\u5f18\u751f\u3001\u4e09\u6c60\u5fe0\u3001\u7530\u539f\u826f\u535a\u3001\u6cb3\u4e0a\u6d0b\u3001\u5bae\u5d0e\u5eb7\u5e78\u3001\u6c60\u7530\u62d3\u4eba\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6b66\u91ce\u614e\u7950\u3001\u4e03\u5cf6\u7be4\u5fd7\u3001\u4e0b\u7530\u548c\u54c9. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u306b\u3066\u52a0\u7642\u4e2d\u306b\u56de\u8178\u7a7f\u5b54\u3092\u6765\u3057\u305f\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5\u306e1\u4f8b.\u7b2c104\u56de\u65e5\u672c\u6d88\u5316\u5668\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac\u30014\/19,2018\uff09<\/li>\n
        3. Yamashita A, Kuroiwa Y, Uchida A, Maekawa K, Gi T, Imamura T, Asada Magnetic resonance T1 high signal intensity in coronary atherosclerotic plaques reflects intraplaque hemorrhage-derived erythrocyte content ATVB\/PVD2018 (San Francisco, 5\/10-12, 2018)<\/li>\n
        4. Watanabe Y, Koyama S, Yamashita A, Kitamura K, Asada Y. Indoleamine 2,3-dioxygenase 1 is expressed in macrophages in human coronary atherosclerotic plaque and is associated with tissue factor expression in activated THP-1 macrophages. ATVB\/PVD2018 (San Francisco, 5\/10-12, 2018)<\/li>\n
        5. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u963f\u842c\u7d2b\u3001\u798f\u5cf6\u525b\u3001\u798f\u5cf6\u548c\u5b50\u3001\u5927\u897f\u6df3\u4ec1\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u660e\u7d30\u80de\u764c\u3068\u6f3f\u6db2\u6027\u764c\u3068\u306e\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u5b50\u5bae\u5185\u819c\u764c\u306e\u4e00\u4f8b. \u7b2c48\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u5f18\u524d\u5e02 5\/19\uff09<\/li>\n
        6. \u8ca1\u90e8\u611b\u83dc\u3001\u5f8c\u7530\u512a\u9999\u3001\u897f\u5143\u9806\u5b50\u3001\u6301\u7530\u8015\u4ecb\u3001\u963f\u842c\u7d2b\u3001\u76db\u53e3\u6df8\u9999\u3001\u5929\u91ce\u6b63\u5b8f. IgA\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u7684\u67d3\u8272\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u591a\u4e2d\u5fc3\u6027\u30ad\u30e3\u30c3\u30b9\u30eb\u30de\u30f3\u75c5\u306e1\u4f8b. \u7b2c117\u56de\u65e5\u672c\u5e9c\u76ae\u819a\u79d1\u5b66\u4f1a\u7dcf\u4f1a\uff08\u5e83\u5cf6\u5e02 5\/31-6\/3\uff09<\/li>\n
        7. \u91ce\u53e3\u88d5\u53f2, \u5fb3\u6e80\u8cb4\u5b50, \u5927\u91ce\u62db\u4f38, \u68ee\u7530\u52dd\u4ee3, \u5cf0\u677e\u6620\u5b50, \u9ed2\u6728\u6804\u8f1d, \u897f\u5ddd\u8a69\u7e54, \u76db\u53e3\u6df8\u9999, \u4f50\u85e4\u52c7\u4e00\u90ce.\u30ea\u30f3\u30d1\u7bc0\u637a\u5370\u7d30\u80de\u8a3a\u306b\u3066\u5224\u5b9a\u306b\u82e6\u616e\u3057\u305f\u8840\u7ba1\u514d\u75ab\u82bd\u7403\u6027T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u4f8b. \u7b2c59\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u8a3a\u5b66\u4f1a (\u672d\u5e4c\u5e02\u30016\/1-3, 2018)<\/li>\n
        8. \u5fb3\u6e80\u8cb4\u5b50, \u91ce\u53e3\u88d5\u53f2, \u5927\u91ce\u62db\u4f38, \u68ee\u7530\u52dd\u4ee3, \u5cf0\u677e\u6620\u5b50, \u9ed2\u6728\u6804\u8f1d, \u897f\u5ddd\u8a69\u7e54, \u963f\u842c\u7d2b, \u524d\u5ddd\u548c\u4e5f, \u4f50\u85e4\u52c7\u4e00\u90ce. \u81b5\u5c3e\u90e8\u816b\u7624\u306eEUS-FNA\u3067\u78ba\u5b9a\u8a3a\u65ad\u306b\u81f3\u3089\u306a\u304b\u3063\u305f1\u4f8b.\u7b2c59\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u8a3a\u5b66\u4f1a\uff08\u672d\u5e4c\u5e02\u30016\/1-3, 2018\uff09<\/li>\n
        9. Kuroiwa Y, Yamashita A, ,Gi T, Mizutani Y, Asanuma T, Miyati T, Imamura T, Asada Y. Detection of early phase of deep vein thrombosis with diffusion-weighted magnetic resonance imaging. Joint Annual Meeting ISMRM-ESMRMB (Paris, 6\/16-21, 2018).<\/li>\n
        10. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u6728\u4f50\u8cab\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u65b0\u751f\u5150\u30eb\u30fc\u30d7\u30b9\u75c7\u5019\u7fa4\u306e\u80ce\u76e4\u6240\u898b. \u7b2c107\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u672d\u5e4c\u5e02\u30016\/21-23, 2018)<\/li>\n
        11. \u5185\u7530\u6681\u5b50\uff0c\u5c71\u4e0b\u3000\u7be4\uff0c\u9ed2\u5ca9\u9756\u6df3\uff0c\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108MRI T1\u5f37\u8abf\u753b\u50cf\u306b\u304a\u3051\u308b\u9ad8\u4fe1\u53f7\u306f\u30d7\u30e9\u30fc\u30af\u5185\u51fa\u8840\u306e\u8d64\u8840\u7403\u6210\u5206\u3092\u53cd\u6620\u3059\u308b.\u7b2c107\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u672d\u5e4c\u5e02\u30016\/21-23, 2018\uff09<\/li>\n
        12. \u524d\u5ddd\u548c\u4e5f\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u897f\u5e73\u8ce2\u4f5c\u3001\u7560\u5c71\u91d1\u592a\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u5185\u306e\u708e\u75c7\u3068\u4f4e\u9178\u7d20\u523a\u6fc0\u304c\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306e\u7d44\u7e54\u56e0\u5b50\u3084\u7cd6\u4ee3\u8b1d\u9175\u7d20\u767a\u73fe\u3092\u4ea2\u9032\u3055\u305b\u308b. \u7b2c40\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u672d\u5e4c\u5e02\u30016\/28-30, 2018\uff09<\/li>\n
        13. \u9ed2\u5ca9\u9756\u6df3\uff0c\u5c71\u4e0b\u3000\u7be4\uff0c\u5185\u7530\u6681\u5b50\uff0c\u5bae\u5730\u5229\u660e, \u4e45\u5ce9\u5c1a\u4e5f\uff0c\u4eca\u6751\u5353\u90ce\uff0c\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306b\u304a\u3051\u308bT1\u5f37\u8abf\u753b\u50cf\u9ad8\u4fe1\u53f7\u306f\u30d7\u30e9\u30fc\u30af\u5185\u51fa\u8840\u3092\u53cd\u6620\u3059\u308b. \u7b2c40\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u672d\u5e4c\u5e02\u30016\/28-30, 2018\uff09<\/li>\n
        14. \u5927\u6817\u4f38\u884c\uff0e\u5fc3\u819c\u6b20\u640d\u3078\u306e\u5fc3\u5d4c\u9813\u306b\u3088\u308a\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u3092\u767a\u75c7\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c91\u56de\u4e5d\u5dde\u75c5\u7406\u96c6\u8ac7\u4f1a\uff08\u718a\u672c\u5e02\u30017\/7\u30012018\uff09<\/li>\n
        15. \u5c71\u4e0b\u3000\u7be4\u3001\u6749\u7530\u5343\u6cf0\u3001\u76db\u53e3\u6e05\u9999\u3001\u53e4\u5c0f\u8def\u82f1\u4e8c\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u65b0\u9bae\u9759\u8108\u8840\u6813\u306e\u6307\u6a19\u3068\u306a\u308b\u4ee3\u8b1d\u7523\u7269\u306e\u540c\u5b9a. \u7b2c5\u56de\u65e5\u672c\u30a6\u30b5\u30ae\u30d0\u30a4\u30aa\u30b5\u30a4\u30a8\u30f3\u30b9\u7814\u7a76\u4f1a\uff08\u795e\u6238\u5e02, 7\/20, 2018\uff09<\/li>\n
        16. \u524d\u5ddd\u548c\u4e5f\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u5cf0\u677e\u6620\u5b50\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5927\u91ce\u62db\u4f38\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u9838\u90e8\u30ea\u30f3\u30d1\u7bc0\u7a7f\u523a\u5438\u5f15\u7d30\u80de\u8a3a\u3067\u5375\u5de3Dysgerminoma\u306e\u8ee2\u79fb\u3092\u63a8\u5b9a\u3057\u5f97\u305f\u4e00\u4f8b\uff0e\u7b2c34\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a \uff08\u9577\u5d0e\u5e02\u30017\/21-22, 2018\uff09<\/li>\n
        17. Sato Y, Maekawa K, Yamashita A, Asada Y, Sameshima H. Clinicopathogical features of chronic histiocytic intervillositis. 24th International Federation of Placenta Associations 2018 (Tokyo, 9\/21-24, 2018)<\/li>\n
        18. Chih-Han Hsu and Sato Y. Ovarian tumor (a 28-year old). The 7th Taiwan-Japan Co-joint Slide Conference of IAP. (Taipei, 10\/27-28, 2018)<\/li>\n
        19. \u5c71\u4e0b\u3000\u7be4\uff0c\u9ed2\u5ca9\u9756\u6df3\uff0c\u5185\u7530\u6681\u5b50\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306eMRIT1\u5f37\u8abf\u753b\u50cf\u9ad8\u4fe1\u53f7\u3068\u30d7\u30e9\u30fc\u30af\u5185\u51fa\u8840\u306e\u95a2\u9023. \u7b2c23\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a\uff08\u4e0b\u95a2\u5e02\u300111\/10\u30012018\uff09<\/li>\n
        20. \u9b4f\u3000\u5cfb\u6d38\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9ed2\u5ca9\u9756\u6df3\u3001\u5c0f\u897f\u3000\u7950\u3001\u6d45\u6cbc\u6b66\u654f\u3001\u4eca\u6751\u5353\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u9759\u8108\u8840\u6813\u306e\u75c5\u7406\u7d44\u7e54\u50cf\u3068\u62e1\u6563\u5f37\u8abf\u78c1\u6c17\u5171\u9cf4\u753b\u50cf. \u7b2c23\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a\uff08\u4e0b\u95a2\u5e02\u300111\/10\u30012018\uff09<\/li>\n
        21. \u798f\u7530\u65e9\u7e54, \u4f50\u91ce\u4e9c\u7531\u7f8e\u3001\u6728\u4f50\u8cab\u7be4\u3001\u4f50\u85e4\u52c7\u4e00\u90ce. \u5b50\u5bae\u9838\u90e8\u539f\u767a\u30ea\u30f3\u30d1\u4e0a\u76ae\u816b\u69d8\u764c\u306e1\u4f8b.\u7b2c57\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u8a3a\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a (\u6a2a\u6d5c\u5e02\u300111\/17-18, 2018)<\/li>\n
        22. \u9b4f\u3000\u5cfb\u6d38\u3001\u91cd\u8349\u8cb4\u6587\u3001\u576a\u5185\u5b8f\u4f38\u3001\u677e\u5143\u4fe1\u5f18\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u963f\u842c\u3000\u7d2b\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u934b\u5cf6\u4e00\u6a39\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u9589\u585e\u6027\u7d30\u6c17\u7ba1\u652f\u708e\u306b\u3088\u308a\u6162\u6027\u80ba\u79fb\u690d\u7247\u6a5f\u80fd\u4e0d\u5168\u3092\u304d\u305f\u3057\u305f\u4e00\u5256\u691c\u75c7\u4f8b. \u7b2c64\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u671f\u7279\u5225\u7dcf\u4f1a\uff08\u5449\u5e02\u300111\/22-23\u30012018\uff09<\/li>\n
        23. \u524d\u5ddd\u548c\u4e5f, \u76db\u53e3\u6e05\u9999, \u6d45\u7530\u7950\u58eb\u90ce.\u3000\u809d\u786c\u5909\u3001von Meyenburg complex\u3092\u80cc\u666f\u306b\u751f\u3058\u305f\u80c6\u7ba1\u764c\u306e\u4e00\u4f8b. \u7b2c64\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u671f\u7279\u5225\u7dcf\u4f1a \uff08\u5449\u5e02\u300111\/22-23, 2018\uff09<\/li>\n<\/ol>\n

          \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/strong><\/p>\n

            \n
          1. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u30d7\u30e9\u30fc\u30af\u3073\u3089\u3093\u3068\u8840\u6d41\u30fb\u8840\u6813\u5f62\u6210. \u7b2c50\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u3001\u660e\u65e5\u3078\u306e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u5927\u962a\u5e02\u30017\/12-14, 2018\uff09<\/li>\n
          2. \u5c71\u4e0b\u3000\u7be4\uff1a\u8840\u6813\u5f62\u6210\u306b\u304a\u3051\u308b\u5185\u56e0\u7cfb\u51dd\u56fa\u56e0\u5b50\u306e\u95a2\u4e0e\uff1a\u7b2cXI\u56e0\u5b50\u306e\u5f79\u5272. \u7b2c59\u56de\u65e5\u672c\u8108\u611f\u5b66\u4f1a\u7dcf\u4f1a\u3001\u7b2c10\u56deJCAC\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u5e83\u5cf6\u5e02\u300110\/25, 2018\uff09<\/li>\n<\/ol>\n

            \u6559\u80b2\u8b1b\u6f14<\/strong><\/p>\n

              \n
            1. \u4f50\u85e4\u52c7\u4e00\u90ce\u3000\u80ce\u76e4\u75c5\u7406\u3068\u8840\u6db2\u51dd\u56fa. \u7b2c58\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u30fb\u65b0\u751f\u5150\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\u5bae\u5d0e\u5e02\u30016\/16, 2018\uff09<\/li>\n<\/ol>\n

              \u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9<\/strong><\/p>\n

                \n
              1. \u5927\u6817\u4f38\u884c\uff1a\u9f3b\u8154\u5185\u816b\u760d\u3000(Olfactory neuroblastoma).
                \n\u7b2c362\u56de\uff08\u56fd\u7acb\u75c5\u9662\u6a5f\u69cb\u9577\u5d0e\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u3001\u5927\u6751\u5e02\uff09<\/li>\n
              2. \u524d\u5ddd\u548c\u4e5f\uff1a\u80c3\u75c5\u5909 (Inflammatory fibroid polyp)\uff0e
                \n\u7b2c363\u56de\uff08\u4e5d\u5dde\u5927\u5b66\u3001\u798f\u5ca1\u5e02\uff09<\/li>\n
              3. \u9b4f\u3000\u5cfb\u6d38\uff1a\u814e\u816b\u760d\u3000(Clear cell papillary renal cell carcinoma).
                \n\u7b2c364\u56de\uff08\u718a\u672c\u5927\u5b66\u3001\u718a\u672c\u5e02\uff09<\/li>\n
              4. \u9b4f\u3000\u5cfb\u6d38\uff1a\u81b5\u5c3e\u90e8\u816b\u760d\u3000(Intraductal papillary mucinous carcinoma).
                \n\u7b2c365\u56de\uff08\u798f\u5ca1\u5927\u5b66\u3001\u798f\u5ca1\u5e02\uff09<\/li>\n
              5. \u5409\u677e\u771f\u4e5f\uff1a\u8776\u5f62\u9aa8\u816b\u760d\u3000(Paraganglioma).
                \n\u7b2c366\u56de\uff08\u5317\u4e5d\u5dde\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u3001\u5317\u4e5d\u5dde\u5e02\uff09<\/li>\n<\/ol>\n

                \u4e5d\u5dde\u75c5\u7406\u96c6\u8ac7\u4f1a<\/strong><\/p>\n

                  \n
                1. \u5927\u6817\u4f38\u884c\uff0e\u5fc3\u819c\u6b20\u640d\u3078\u306e\u5fc3\u5d4c\u9813\u306b\u3088\u308a\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u3092\u767a\u75c7\u3057\u305f\u4e00\u4f8b\uff0e
                  \n\u7b2c91\u56de\uff08\u718a\u672c\u5e02\uff09<\/li>\n<\/ol>\n

                  \u53d7\u8cde<\/strong><\/p>\n

                    \n
                  1. \u4e2d\u6751\u6075\u7406\u5b50.\u3000\u5e73\u621029\u5e74\u5ea6\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u4e5d\u5dde\u6c96\u7e04\u652f\u90e8\u512a\u79c0\u75c7\u4f8b\u5831\u544a\u8cde
                    \n\u508d\u7cf8\u7403\u4f53\u7d30\u80de\u816b\u306e1\u4f8b.<\/li>\n
                  2. \u4e2d\u6751\u6075\u7406\u5b50.\u3000Journal of atherosclerosis and thrombosis award 2017
                    \nAsymptomatic Plaque of Lower Peripheral Arteries and Their Association with Cardiovascular Disease: An Autopsy Study.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                    \u539f\u8457\u8ad6\u6587 Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Nishii R, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y. In vitr … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":96,"featured_media":0,"parent":17,"menu_order":-13,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/240"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/comments?post=240"}],"version-history":[{"count":6,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/240\/revisions"}],"predecessor-version":[{"id":590,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/240\/revisions\/590"}],"up":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/17"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/media?parent=240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}